Immunohistochemical assessment of PTEN in vulvar cancer: Best practices for tissue staining, evaluation, and clinical association
Abstract
No abstract availableKeywords
Funding Information
- CNPq
- FAPESP
- CAPES
This publication has 17 references indexed in Scilit:
- Molecular Pathways: Intercellular PTEN and the Potential of PTEN Restoration TherapyClinical Cancer Research, 2014
- Best practice for PTEN gene and protein assessment in anatomic pathologyActa Histochemica, 2014
- MGMT and PTEN as potential prognostic markers in breast cancerExperimental and Molecular Pathology, 2012
- PTEN: a new guardian of the genomeOncogene, 2008
- FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcomeBritish Journal of Cancer, 2007
- Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalitiesLaboratory Investigation, 2005
- Protean PTEN: Form and FunctionThe American Journal of Human Genetics, 2002
- Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the BreastThe American Journal of Pathology, 1999
- The lipid phosphatase activity of PTEN is critical for its tumor supressor functionProceedings of the National Academy of Sciences, 1998
- P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphataseProceedings of the National Academy of Sciences, 1997